ArticleDiscover oncology2024

TMEM173 is a biomarker of predicting prognosis, immune responses and therapeutic effect in human lung adenocarcinoma.

Pingting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.